1. Home
  2. PT vs NKGN Comparison

PT vs NKGN Comparison

Compare PT & NKGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PT
  • NKGN
  • Stock Information
  • Founded
  • PT 2012
  • NKGN 2017
  • Country
  • PT China
  • NKGN United States
  • Employees
  • PT N/A
  • NKGN N/A
  • Industry
  • PT Computer Software: Programming Data Processing
  • NKGN Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PT Technology
  • NKGN Health Care
  • Exchange
  • PT Nasdaq
  • NKGN Nasdaq
  • Market Cap
  • PT 14.8M
  • NKGN 14.1M
  • IPO Year
  • PT 2018
  • NKGN N/A
  • Fundamental
  • Price
  • PT $0.92
  • NKGN $0.25
  • Analyst Decision
  • PT
  • NKGN
  • Analyst Count
  • PT 0
  • NKGN 0
  • Target Price
  • PT N/A
  • NKGN N/A
  • AVG Volume (30 Days)
  • PT 39.3K
  • NKGN 352.0K
  • Earning Date
  • PT 04-30-2024
  • NKGN 11-12-2024
  • Dividend Yield
  • PT N/A
  • NKGN N/A
  • EPS Growth
  • PT N/A
  • NKGN N/A
  • EPS
  • PT N/A
  • NKGN N/A
  • Revenue
  • PT $7,434,458.00
  • NKGN N/A
  • Revenue This Year
  • PT N/A
  • NKGN N/A
  • Revenue Next Year
  • PT N/A
  • NKGN N/A
  • P/E Ratio
  • PT N/A
  • NKGN N/A
  • Revenue Growth
  • PT N/A
  • NKGN N/A
  • 52 Week Low
  • PT $0.71
  • NKGN $0.25
  • 52 Week High
  • PT $1.38
  • NKGN $5.10
  • Technical
  • Relative Strength Index (RSI)
  • PT 43.06
  • NKGN 21.48
  • Support Level
  • PT $0.86
  • NKGN $0.36
  • Resistance Level
  • PT $1.01
  • NKGN $0.44
  • Average True Range (ATR)
  • PT 0.12
  • NKGN 0.04
  • MACD
  • PT -0.01
  • NKGN 0.00
  • Stochastic Oscillator
  • PT 44.44
  • NKGN 0.00

About PT Pintec Technology Holdings Limited

Pintec Technology Holdings Ltd is a technology platform that provides financial services in China in terms of loan volume facilitated. The company connects business partners and financial partners on its open platform and enables them to provide financial services to end-users. Its products include installment loans, personal loans, wealth management, insurance brokerage, SME loans, and others. The company generates its revenue from technical service fees also by providing financing for these borrowers and earn installment service fees, They earn wealth management services fees and commission on financial products.

About NKGN NKGen Biotech Inc.

NKGen Biotech Inc is a biotechnology company developing cell therapies for neurodegenerative and oncological diseases based on activated NK cells. NK cells are part of the human innate immune response system that can selectively identify and destroy abnormal or diseased cells. Its product candidates are based on a proprietary manufacturing and cryopreservation process that produces SuperNKTM (SNK) cells that have shown increased activity as compared to the starting population of NK cells, based on the results of in vitro experiments performed by NKMAX, as defined by parameters such as cytotoxicity, cytokine production and activating receptor expression. SNK cells can be produced in large quantities and cryopreserved while maintaining high levels of cytotoxicity.

Share on Social Networks: